WILKISON; William Owen
Patent Applications and Registrations
Patent applications and USPTO patent grants for WILKISON; William Owen.The latest application filed is for "use of sglt2 inhibitors to treat primary sclerosing cholangitis".
- WILKISON; William Owen - Raleigh NC
| Patent | Date |
|---|---|
| Use Of Sglt2 Inhibitors To Treat Primary Sclerosing Cholangitis App 20210393662 - WILKISON; William Owen ; et al. | 2021-12-23 |
| Method For Treating Primary Sclerosing Cholangitis App 20210322324 - WILKISON; William Owen ; et al. | 2021-10-21 |
| Combination immediate/delayed release delivery system for short half-life pharmaceuticals including remogliflozin Grant 10,940,159 - Green , et al. March 9, 2 | 2021-03-09 |
| Combination Immediate/delayed Release Delivery System For Short Half-life Pharmaceuticals Including Remogliflozin App 20130209563 - Green; James Trinca ; et al. | 2013-08-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 